Shelly Gunn

The Clinical Effect of the Dual-Targeting Strategy Involving PI3K/AKT/mTOR and RAS/MEK/ERK Pathways in Patients with Advanced Cancer

Toshio Shimizu, Anthony W. Tolcher, Kyriakos P. Papadopoulos et al. · Clinical Cancer Research · 2012 · 432 citations

Medicine, Oncology, Pharmacology +17

Clinical validation of an array CGH test for HER2 status in breast cancer reveals that polysomy 17 is a rare event

I‐Tien Yeh, Mathew A Martin, Ryan S. Robetorye et al. · Modern Pathology · 2009 · 144 citations · Full text

Medicine, Cancer Biology, Oncology +13

Molecular characterization of a patient with central nervous system dysmyelination and cryptic unbalanced translocation between chromosomes 4q and 18q

Shelly Gunn, Xavier T. Reveles, David Viskochil et al. · American Journal of Medical Genetics Part A · 2003 · 109 citations

Life Sciences, Genetics, Molecular Genetics +17

Whole-Genome Scanning by Array Comparative Genomic Hybridization as a Clinical Tool for Risk Assessment in Chronic Lymphocytic Leukemia

Shelly Gunn, M. Gorre, Philip D. Cotter et al. · Journal of Molecular Diagnostics · 2008 · 78 citations

Life Sciences, Genetics, Oncology +11

Molecular and clinical characterization of a recurrent cryptic unbalanced t(4q;18q) resulting in an 18q deletion and 4q duplication

Craig Horbinski, Erika M. Carter, Patricia Heard et al. · American Journal of Medical Genetics Part A · 2008 · 76 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16